Diltiazem suppresses collagen synthesis and IL-1β-induced TGF-β1 production on human peritoneal mesothelial cells

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1340-1347

  Fang, Cheng Chung ^a   Yen, Chung Jen ^b   Chen, Yung Ming ^b   Chu, Tzong Shinn ^b   Lin, Ming Tsan ^a   Yang, Ju Yeh ^b   Tsai, Tun Jun ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diltiazem; IL 1 ; Mitogen activated protein kinase; Peritoneal mesothelial cell; Signalling pathway; TGF 1

Indexed keywords

CALCIUM; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DILTIAZEM; FURA 2 ACETOXYMETHYL ESTER; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPSIN A; PROLINE; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ARTICLE; CELL CULTURE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOASSAY; IN VIVO STUDY; INHIBITION KINETICS; KIDNEY FAILURE; MESOTHELIUM CELL; NORTHERN BLOTTING; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN; DILTIAZEM; EPITHELIAL CELLS; FIBROSIS; HUMANS; INTERLEUKIN-1; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646181455     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk051     Document Type: Article

References (35)

1. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
2. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341-356
3. Yung S, Chan TM. Peritoneal mesothelial cells and the extracellular matrix. Nephrology 2001; 6: 250-258
4. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C. Human peritoneal mesothelial cells synthesize IL-1 alpha and beta. Kidney Int 1994; 46: 993-1001
5. Offner FA, Feichtinger H, Stadlmann S et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-1688
6. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61: 570-578
7. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506
8. Breborowicz A, Oreopoulos DG. Evidence for the presence of chronic inflammation during peritoneal dialysis: Therapeutic implications. Perit Dial Int 1997; 17: S37-S41
9. Pecoits-Filho R, Stenvinkel P, Wang AY-M, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: The search for the holy grail? Perit Dial Int 2004; 24: 327-339
10. Topley N, Liberek T, Davenport A, Li F-K, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int 1996; 50: S17-S21
11. Margetts PJ, Kolb M, Yu L et al. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 2002; 160: 2285-2294
12. Roberts AB, McCune BK, Sporn MB. TGF-beta: Regulation of extracellular matrix. Kidney Int 1992; 41: 557-559
13. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-2039
14. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-541
15. Yung S, Chan TM. Preventing peritoneal fibrosis - insights from the laboratory. Perit Dial Int 2003; 23: S37-S41
16. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA 1996; 93: 5478-5482
17. D'Ambrosio A, Giacomini E, Camponeschi B, Quintieri F. Diltiazem modulates monokine production in human mixed lymphocyte culture. Transplantation 1998; 65: 1411-1413
18. D'Ambrosio A, Bachetoni A, Giacomini E, Quaranta M, Quintieri F. Diltiazem downregulates IL-12 production by human dendritic cells. Transplant Proc 2001; 33: 236-239
19. Fang CC, Yen CJ, Chen YM et al. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis - effects on TGFβ. Kidney Int 2000; 57: 2626-2633
20. Chang CC, Wu YC, Chiu HC, Liu YL, Lu YC. Pentoxifylline inhibits the proliferation of human fibroblasts derived from normal, hypertrophic scar and keloid skin and their mitochondrial activity and collagen synthesis. Eur J Dermatol 1991; 1: 214-220
21. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995; 270: 13585-13588
22. Cuenda A, Rouse J, Doza YN et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364: 229-233
23. Bennett BL, Sasaki DT, Murray BW et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13686
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450
25. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27
26. Okada H, Inoue T, Kanno Y et al. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int 2003; 64: 1722-1732
27. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
28. Crenesse D, Tornieri K, Laurens M et al. Diltiazem reduces apoptosis in rat hepatocytes subjected to warm hypoxia-reoxygenation. Pharmacology 2002; 65: 87-95
29. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Slow channel calcium inhibition blocks proinflammatory gene signalling and reduces macrophage responsiveness. J Trauma 2002; 52: 434-442
30. Lo C-J, Garcia I, Cryer HG, Maier RV. Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch Surg 1996; 131: 44-50
31. Sugiura T, Imai E, Moriyama T, Horio M. Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: Possible mechanism of suppression of AP-1 and CREB activities. Nephron 2000; 85: 71-80
32. Kelly JG, O'Malley K. Clinical pharmacokinetics of calcium antagonists. An update. Clin Pharmacokinet 1992; 22: 416-433
33. Thitiarchakul S, Lal SM, Moore HL, Nolph KD. Effects of chlorpromazine or diltiazem given intraperitoneally alone or in combination on peritoneal transport of solute and water. Adv Perit Dial 1999; 15: 7-11
34. Combet S, Ferrier M-L, van Landschoot M et al. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 2001; 12: 2146-2157
35. Plum J, Fleisch MC, Razeghi P, Fussholler A, Lordnejad MR, Grabensee B. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells. Kidney Blood Pressure Res 2002; 25: 195-201